Advanced search
Publication Cover
Issues in Mental Health Nursing Volume 25, 2004 - Issue 7
Submit an article Journal homepage
113
Views
8
CrossRef citations to date
0
Altmetric
Research Article

A DESCRIPTIVE STUDY OF THE RELATIONSHIP BETWEEN MOOD DISORDERS AND HEPATITIS C TREATMENT COMPLIANCE: DOES NURSING PLAY A ROLE?

Janice M. Strinko Gastroenterology and Hepatology, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri, USACorrespondence[email protected]
, RN, BSN,
Di Adrian M. Bisceglie Gastroenterology and Hepatology, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri, USA
, MD &
Joyce A. Hoffmann Gastroenterology and Hepatology, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri, USA
Pages 715-722 | Published online: 09 Jul 2009

REFERENCES

  • Centers for Disease Control, National Institutes of Health, Consensus Development Conference Statement; Management of Hepatitis C: 2002, 2002, June 10–12. Retrieved July 21, 2003, from, http://consensus.nih.gov/cons/116/Hepc091202.pdf
  • Dierperink E., Ho S. B., Thuras P., Willenbring M. L.. 2003. A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C. Psychosomatics. 44(2)104–112
  • El-Serag H. B., Kunik M., Richardson P., Rabeneck L.. 2002. Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology. 123(2)467–482
  • Fried M. W., Shiffman M. L., Reddy K. R., Smith C., Marinos G., Goncales F. L., Haussinger D., Diago M., Carosi G., Dhumeaux D., Craxi A., Lin A., Hoffman J., Yu J.. 2002. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. The New England Journal of Medicine. 347(13)975–982. [CROSSREF], [PUBMED], [INFOTRIEVE]
  • Hauser P., Khosla J., Aurora H., Laurin J., Kling M. A., Hill J., Gulati M., Thornton A. J., Schultz R. L., Valentine A. D., Meyers C. A., Howell C. D.. 2002. A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C. Molecular Psychiatry. 7(9)942–947. [CROSSREF], [PUBMED], [INFOTRIEVE]
  • Johnson M. E., Fisher D. G., Fenaughty A., Theno S. A.. 1998. Hepatitis C virus and depression in drug users. American Journal of Gastroenterology. 93(5)785–789. [CROSSREF], [PUBMED], [INFOTRIEVE]
  • Kraus M. R., Schafer A., Faller H., Csef H., Scheurlen M.. 2002. Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 16(6)1091–1099. [CROSSREF]
  • Kyngas H. A.. 2000. Nurses' support: Essential factor for the good compliance of adolescents with asthma. Nursing and Health Sciences. 2(4)211–216
  • Leone N. E.. 2002. The role of nursing in managing treatment-associated adverse effects in patients with hepatitis C. Gastroenterology Nursing. 25(5)201–203. [PUBMED], [INFOTRIEVE]
  • Morgan L.. 2000. A decade review: Methods to improve adherence to the treatment regimen among hemodialysis patients. Nephrology Nursing Journal: Journal of the American Nephrology Nurses' Association. 27(3)299–304
  • National Digestive Diseases Information Clearinghouse, 2003, February. Chronic Hepatitis C: Disease Management. Treatment Section, NIH Publication No. 03–4230. Retrieved July 21, 2003, from. http://www.niddk.nih.gov/health/digest/pubs/chrnhepc/chrnhepc.htm#H
  • Roche Pharmaceuticals, 2002. Copegus (ribavirin, USP) tablets. Package insert, Roche Laboratories, Inc., Issued, December 2002.
  • Sivesind D., Baile W. F.. 2001. The psychologic distress of patients with cancer. Nursing Clinics of North America. 36(4)809–825. [PUBMED], [INFOTRIEVE]
  • Trask P. C., Esper P., Riba M., Redman B.. 2000. Psychiatric side effects of Interferon therapy: prevalence, proposed mechanisms, and future directions. Journal of Clinical Oncology. 18(11)2316–2326. [PUBMED], [INFOTRIEVE]
  • Valentine A. D., Meyers C. A., Kling M. A., Richelson E., Hauser P.. 1998. Mood and cognitive side effects of interferon-alpha therapy. Seminars in Oncology. 25, (Suppl 1). 39–47. [PUBMED], [INFOTRIEVE]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.